Hidden fungal threats in the ICU: a deep dive into drug-resistant infections
NCT ID NCT06387667
First seen Jul 30, 2026 · Last updated Jul 31, 2026 · Updated 1 time
Summary
This study aims to identify the types of fungi causing pneumonia in immunocompromised ICU patients and test how resistant they are to antifungal drugs. Researchers will collect samples from 250 adults in intensive care who have pneumonia that does not respond to antibiotics. The goal is to better understand which fungi are involved and what patient factors may be linked to drug resistance.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better identify and treat dangerous fungal infections in vulnerable ICU patients, potentially reducing deaths.
- What could go wrong
- This is an observational study, not a treatment trial, so it will not directly test any new therapy. The findings may not apply to all hospitals or patient groups.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IMMUNOCOMPROMISED ICU PATIENTS WITH RESPIRATORY TRACT INFECTIONS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assiut University
RECRUITINGAsyut, 71511, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.